Myosin Therapeutics Inc.
Clinical trials sponsored by Myosin Therapeutics Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New brain cancer drug combo enters first human tests Results expected Oct 2026 (estimated)
- New drug combo targets aggressive brain cancer in early trial Results expected Mar 2027 (estimated)